Puma Biotechnology | PBYI - Modal Pinjaman





Modal Pinjaman Perubahan Tanggal
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
Amgen USD 50B 2.43B 2025-12
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 597.18M 513K 2025-12
Daiichi Sankyo JPY 300.15B 199.41B 2025-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
Glaxosmithkline GBP 19.82B 203.13M 2025-12
Incyte USD 30.2M 5.17M 2025-12
MacroGenics USD 70M 256K 2025-12
Moderna USD 610M 584M 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 2.03B 193.22M 2025-12
Puma Biotechnology USD 10.87M 222K 2025-06
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Sarepta Therapeutics USD 828.97M 206.17M 2025-12
Takeda JPY 4.27T 81.29B 2025-12
TG Therapeutics USD 245.64M 305K 2025-12
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03